03.08.2012
- German healthcare conglomerate Fresenius may raise its 2012 profit outlook for a third time this year as its injectable generic drugs unit Kabi continues to benefit from rivals'...
21.07.2012
- Aggressive consolidation among U.S. and European generic drugmakers is putting pressure on smaller competitors in the industry, whose best hope of surviving a brewing price war may...
11.06.2012
- German healthcare conglomerate Fresenius on Monday raised its 2012 profit outlook for a second time this year as its injectable generic drugs unit Kabi continues to benefit from...
